GlassScriptPhysician profile
Laura M Corsini
NPI 1376957563
$4,189.54
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $517 · 2021: $1,428 · 2022: $781.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.33 | 2019-2022 | |
| Galderma Laboratories, L.P. | $607.32 | 2019-2022 | |
| Janssen Biotech, INC. | $540.17 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $372.88 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $242.22 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $193.31 | 2019-2022 | |
| Lilly USA, LLC | $186.47 | 2019-2022 | |
| Pfizer INC. | $156.70 | 2019-2022 | |
| Leo Pharma INC. | $148.26 | 2019-2021 | |
| Ucb, INC. | $128.26 | 2019-2020 | |
| Allergan, INC. | $113.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $102.35 | 2021 | |
| Incyte Corporation | $64.13 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $62.71 | 2019 | |
| Dermira, INC. | $61.06 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.32 | 2019-2021 | |
| Hologic Sales and Service, LLC | $54.30 | 2019-2020 | |
| Helsinn Therapeutics (U.S.), INC. | $50.16 | 2021-2022 | |
| Genzyme Corporation | $46.74 | 2021-2022 | |
| Promius Pharma LLC | $28.68 | 2019 | |
| Mylan Pharmaceuticals INC. | $26.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.61 | 2021 | |
| Encore Dermatology INC. | $19.05 | 2019 | |
| Almirall LLC | $15.92 | 2021 | |
| Prugen, INC. Pharmaceuticals | $15.46 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $14.82 | 2019 | |
| Amgen INC. | $14.67 | 2019 | |
| Journey Medical Corporation | $14.53 | 2022 | |
| Epi Health, LLC | $12.67 | 2022 | |
| Vyne Pharmaceuticals INC. | $11.42 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Corsini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.